Affiliation:
1. From the Medical Research Council Laboratory of Molecular Biology, Cambridge CB2 2QH, United Kingdom
Abstract
CD22 is a B cell–specific transmembrane glycoprotein that acts to dampen signals generated through the B cell antigen receptor (BCR): B cells from CD22-deficient mice give increased Ca2+ fluxes on BCR ligation. Here we show that this B cell hyperresponsiveness correlates with the development of autoantibodies. After the age of eight months, CD22-deficient mice developed high titers of serum IgG directed against double-stranded DNA; these antibodies were of multiclonal origin, somatically mutated, and high affinity. Increased titers of antibodies to cardiolipin and myeloperoxidase were also noted. The results demonstrate that a single gene defect exclusive to B lymphocytes is, without additional contrivance, sufficient to trigger autoantibody development in a large proportion of aging animals. Thus, CD22 might have evolved specifically to regulate B cell triggering thresholds for the avoidance of autoimmunity.
Publisher
Rockefeller University Press
Subject
Immunology,Immunology and Allergy
Reference43 articles.
1. Lupus susceptibility loci in New Zealand mice;Kono;Proc Natl Acad Sci USA,1994
2. Polygenic control of susceptibility to murine systemic lupus erythematosus;Morel;Immunity,1994
3. Genetic analysis of the NZB contribution to lupus-like autoimmune disease;Drake;Proc Natl Acad Sci USA,1994
4. Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice;Hogarth;J Immunol,1998
5. Evidence for an intrinsic B cell defect in lpr/lprmice apparent in neonatal chimeras;Perkins;J Immunol,1990
Cited by
286 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献